SCHEMBL19130446

SCHEMBL19130446

c1ccc(-c2cccc(-c3cccc(-c4ccc5c(c4)c4ccccc4n5-c4ccc5oc6cccc(-c7nc(-c8ccccc8)nc(-c8ccc9oc%10ccccc%10c9c8)n7)c6c5c4)c3)c2)cc1

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.34
PLA2G4A P47712 3/20 0.34
PLA2G10 O15496 1/20 0.34
CHEK2 O96017 1/20 0.33
PRKDC P78527 1/20 0.31
PIM1 P11309 1/20 0.31
CSNK2A2 P19784 1/20 0.31
CSNK2B P67870 1/20 0.31
PIM3 Q86V86 1/20 0.31
PIM2 Q9P1W9 1/20 0.31
RAC2 P15153 1/20 0.31
RAC3 P60763 1/20 0.31
CDC42 P60953 1/20 0.31
RAC1 P63000 1/20 0.31
HSP90AA1 P07900 1/20 0.31
HSP90AB1 P08238 1/20 0.31
HPSE Q9Y251 1/20 0.30
TSPO P30536 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22258115 0.99 PLA2G2A (0.34) PLA2G2APLA2G4APLA2G10CHEK2PRKDC
SCHEMBL25459414 0.99 PLA2G2A (0.35) PLA2G2APLA2G4APLA2G10CHEK2PRKDC
SCHEMBL19129927 0.99 PLA2G2A (0.34) PLA2G2APLA2G4APLA2G10CHEK2PRKDC
SCHEMBL29324458 0.98 PLA2G2A (0.35) PLA2G2APLA2G4APLA2G10CHEK2PRKDC
SCHEMBL24149025 0.98 PLA2G2A (0.35) PLA2G2APLA2G4APLA2G10CHEK2PRKDC
SCHEMBL26287496 0.98 PLA2G2A (0.35) PLA2G2APLA2G4APLA2G10CHEK2PRKDC
SCHEMBL25459394 0.98 PLA2G2A (0.34) PLA2G2APLA2G4APLA2G10CHEK2PRKDC
SCHEMBL24149856 0.98 PLA2G2A (0.35) PLA2G2APLA2G4APLA2G10CHEK2PRKDC
SCHEMBL19129920 0.98 CHEK2 (0.34) PLA2G2APLA2G4APLA2G10CHEK2PIM1
SCHEMBL19039088 0.98 CHEK2 (0.34) PLA2G2APLA2G4APLA2G10CHEK2PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220165961-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-05-26 US disclosed
US-20170207399-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2017-07-20 US disclosed
US-20170207399-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2017-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170207399-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES DDT, ESD, TST PLA2G2A 3979/4885PLA2G4A 4032/4885PLA2G10 3616/4885
US-20220165961-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES DDT, ESD, TST PLA2G2A 3979/4885PLA2G4A 4032/4885PLA2G10 3616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.